The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 31, 2022

Filed:

Dec. 31, 2018
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Cynthia L. Sears, Baltimore, MD (US);

Drew M. Pardoll, Brookeville, MD (US);

Christine Craig, Baltimore, MD (US);

Elizabeth Wick, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); C12Q 1/04 (2006.01); C12Q 1/68 (2018.01); A61K 31/7056 (2006.01); A61K 31/165 (2006.01); A61K 31/43 (2006.01); A61K 31/546 (2006.01); A61K 31/7048 (2006.01); C12Q 1/689 (2018.01); A61K 31/407 (2006.01); A61K 35/741 (2015.01); A61K 35/742 (2015.01); A61K 35/744 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A61K 45/06 (2006.01); C12Q 1/6841 (2018.01); C12Q 1/6869 (2018.01);
U.S. Cl.
CPC ...
G01N 33/57419 (2013.01); A61K 31/165 (2013.01); A61K 31/407 (2013.01); A61K 31/43 (2013.01); A61K 31/546 (2013.01); A61K 31/7048 (2013.01); A61K 31/7056 (2013.01); A61K 35/741 (2013.01); A61K 35/742 (2013.01); A61K 35/744 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61K 45/06 (2013.01); C12Q 1/04 (2013.01); C12Q 1/689 (2013.01); C12Q 1/6841 (2013.01); C12Q 1/6869 (2013.01); G01N 2800/50 (2013.01); G01N 2800/7028 (2013.01);
Abstract

Methods of identifying subjects at increased risk of cancer, based upon detection of biofilms and/or biofilm-associated microbes within a subject, are disclosed. Therapies designed to prevent formation and/or reduce the size of biofilms in a subject identified to be at increased risk of cancer based upon detection of biofilms and/or biofilm-associated microbes are disclosed. In particular embodiments, the invention provides for identification of a subject at elevated risk of developing or having colorectal cancer and/or a colorectal adenoma, based upon detection of a biofilm and/or biofilm-associated bacteria within the gastrointestinal tract of the subject (optionally, within a biopsy specimen and/or stool sample of such subject). Therapies involving administration of an antibiotic agent and/or a probiotic agent to a subject, to prevent or reduce biofilm formation within the gastrointestinal tract of the subject, optionally provided in combination with additional cancer therapy, are also disclosed.


Find Patent Forward Citations

Loading…